The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chazova I.E.

Federal State budget organization National Medical Research Center of Cardiology of the Ministry of healthcare of the Russian Federation, The Institute of Clinical Cardiology, Moscow, Russia

Karabasheva M.B.

Institute of the Clinical Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, Moscow, Russia

Danilov N.M.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Matchin Yu.G.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Chronic thromboembolic pulmonary hypertension: modern view on the problem

Authors:

Chazova I.E., Karabasheva M.B., Danilov N.M., Matchin Yu.G.

More about the authors

Journal: Russian Cardiology Bulletin. 2019;14(2): 14‑23

DOI: 10.17116/Cardiobulletin20191402114

Read: 7407 times

Download PDF (RU)
Contact the author
Table of contents

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: MODERN VIEW ON THE PROBLEM
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: MODERN VIEW ON THE PROBLEM

To cite this article:

Chazova IE, Karabasheva MB, Danilov NM, Matchin YuG. Chronic thromboembolic pulmonary hypertension: modern view on the problem. Russian Cardiology Bulletin. 2019;14(2):14‑23. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20191402114

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Chronic thromboembolic pulmonary hypertension — a rare, severe, but potentially treatable disease — which, in the absence of timely treatment, progresses steadily, leading to an increase in pulmonary vascular resistance and pressure in the pulmonary artery, with the subsequent development of right ventricular heart failure and an extremely adverse prognosis. In this review article all of the key stages of the of the pathogenesis of the disease are considered, and the current diagnostic capabilities and potential treatments are described.

Keywords:

pulmonary hypertension
chronic thromboembolic pulmonary hypertension
thromboendarterectomy

Authors:

Chazova I.E.

Federal State budget organization National Medical Research Center of Cardiology of the Ministry of healthcare of the Russian Federation, The Institute of Clinical Cardiology, Moscow, Russia

Karabasheva M.B.

Institute of the Clinical Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, Moscow, Russia

Danilov N.M.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Matchin Yu.G.

Institute of Cardiology named after A.L. Myasnikov of National Medical Research Center for Cardiology, 3-rd Cherepkovskay St., 15a, Moscow, 121552, Russian Federation

Close metadata

References:

  1. Chazov EI. Ocherki neotlozhnoy kardiologii. Medicina. Moscow. 1973.
  2. Chazov EI. Trombozi i embolii v klinike vnutrennih bolezney. Medicina. Moscow. 1966.
  3. Chazov EI, Martynuk TV. Klinicheskie rekomendacii po diagnostike i lecheniu khronicheskoi legochnoi tromboembolicheskoi gipertenzii. Terapevticheskiy arkhiv. 2016;10:63-72.
  4. Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4:306-322.
  5. Lang IM, Dorfmüller P, Vonk Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc. 2016; 13(suppl 3):215-221.
  6. Wartski M, Collignon MA. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l’Embolie Pulmonaire Study. J Nucl Med. 2000;41:1043-1048.
  7. Klok FA, van Kralingen KW, van Dijk AP, et al. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010;95:970-975.
  8. Lang I. Chronic thromboembolic pulmonary hypertension: a distinct disease entity. Eur Respir Rev. 2015;24:246-252.
  9. Olsson KM, Meyer B, Hinrichs J, et al. Chronic thromboembolic pulmonary hypertension. Dtsch Arztebl Int. 2014;111:856-862.
  10. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-2264.
  11. Delcroix M, Vonk Noordegraaf A, Fadel E, et al. Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2013;41:224-232.
  12. Guérin L, Couturaud F, Parent F, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Haemost. 2014;112:598-605.
  13. Blauwet LA, Edwards WD, Tazelaar HD, et al. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol. 2003;34:1290-1298.
  14. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest. 1995;107:10-17.
  15. Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33:325-331.
  16. Karimi M, Cohan N. Cancer-associated thrombosis. Open Cardiovasc Med J. 2010;4:78-82.
  17. Wolf M, Boyer-Neumann C, Parent F, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15:395-399.
  18. Banks DA, Pretorius GV, Kerr KM, et al. Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth. 2014;18:319-330.
  19. Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90:372-376.
  20. Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2008;31:736-741.
  21. Marsh JJ, Chiles PG, Liang NC, et al. Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure. Thromb Res. 2013;132:729-734.
  22. Morris TA, Marsh JJ, Chiles PG, et al. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med. 2006;173:1270-1275.
  23. Yaoita N, Satoh K, Satoh T, et al. Thrombin-activatable fibrinolysis inhibitor in chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2016;36:1293-1301.
  24. Zabini D, Nagaraj C, Stacher E, et al. Angiostatic factors in the pulmonary endarterectomy material from chronic thromboembolic pulmonary hypertension patients cause endothelial dysfunction. PLoS One. 2012;7:e43793.
  25. Alias S, Redwan B, Panzenböck A, et al. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioskler. Tromb. Vasc. Biol. 2014;34(4):810-819.
  26. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest. 1993;103:685-692.
  27. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43:25-32.
  28. Dorfmüller P, Günther S, Ghigna MR, et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014;44:1275-1288.
  29. Legochnaya gipertenzia. Chazova IE, Martynyuk TV. Praktika; 2015.
  30. Thistlethwaite PA, Mo M, Madani MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2002;124:1203-1211.
  31. Kim NH, Fesler P, Channick RN, et al. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation. 2004;109:18-22.
  32. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1.500 cases. Ann Thorac Surg. 2003;76:1457-1462.
  33. Chazova IE, Avdeev SN, Careva NA, Martynyuk TV, Volkov AV, Nakonechnikov SN. Klinicheskie rekomendacii po diagnostike i lecheniyu legochnoi gipertenzii. Terapevticheskiy arkhiv. 2014;9:4-23.
  34. Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188:639-646.
  35. Tonelli AR, Haserodt S, Aytekin M, et al. Nitric oxide deficiency in pulmonary hypertension: pathobiology and implications for therapy. Pulm Circ. 2013;3:20-30.
  36. Skoro-Sajer N, Mittermayer F, Panzenboeck A, et al. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2007;176:1154-1160.
  37. Stasch JP, Evgenov OV. Soluble guanylate cyclase stimulators in pulmonary hypertension. Handb Exp Pharmacol. 2013;218:279-313.
  38. Chockalingam A, Gnanavelu G, Venkatesan S, Elangovan S, Jagannathan V, Subramaniam T, Alagesan R, Dorairajan S. Efficacy and optimal dose of sildenafil in primary pulmonary hypertension. Int J Cardiol. 2005;99:91-95.
  39. Mittendorf J, Weigand S, Alonso-Alij C. Discovery of Riociguat (BAY 63-2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension Chem. Med Chem. 2009;4:5:853-865.
  40. Grimminger F, Weimann G, Frey R, et al. First acute haemodynamic study of soluble guanylatecyclase stimulator riociguat in pulmonary hypertension. Eur Respir J. 2009;33:785-792.
  41. Freed DH, Thomson BM, Berman M, et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011;141:383-387.
  42. Timothy M. Fernandes, David S, William R. Auger. Treatment of chronic thromboembolic pulmonary hypertention: the role of medical therapy and balloon pulmonary angioplasty. Methodist Debakey Cardiovasc J. 2016;12(4):205-212.
  43. Jenkins D, Madani M, Fadel E., D’Armini A-M, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. European Respiratory Review. 2017;26:160111.
  44. Lewczuk J, Piszko P, Jagas J, Porada A, Wojciak S, Sobkowicz B, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119:818-823.
  45. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62:92-99.
  46. D’Armini AM, Morsolini M, Mattiucci G, Grazioli V, Pin M, Valentini A, et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2014;148:1005-1011; 1012.e1-e2; discussion 1011-1012.
  47. Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: Recent changes in a single institution’s experience of more than 2.700 patients. Ann Thorac Surg. 2012;94:97-103; discussion 103.
  48. Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation. 2011;124:1973-1981.
  49. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:748-755.
  50. Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76:485-488.
  51. Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:756-762.
  52. Tanabe N, Kawakami T, Satoh T, Matsubara H, Nakanishi N et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A systematic review. Respiratory Investigation. 2018;56:332-341.
  53. Ogawa A, Matsubara H. Balloon pulmonary angioplasty: a treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension, Front. Cardiovasc Med. 2 (February-17-2015) (2014).
  54. Mayer E, Jenkins D, Lindner J, D’Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702-710.
  55. Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long — term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76:485-488.
  56. Pitton MB, Herber S, Mayer E, Thelen M. Pulmonary balloon angioplasty of chronic thromboembolic pulmonary hypertension (CTEPH) in surgically inaccessible cases. Rofo. 2003;175:631-634.
  57. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Rened balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:748-755.
  58. Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76:485-488.
  59. Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:756-762.
  60. Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99:1415-1420.
  61. Lang I, Meyer BC, Ogo T, Matsubara H, Kurzyna M, Ghofrani HA, et al. Balloon pulmonary angioplasty in chronic thrombo- embolic pulmonary hypertension. Eur Respir Rev. 2017;26:pii:160119.
  62. Kurzyna M, Darocha S, Koteja A, Pietura R, Torbicki A. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Postepy Kardiol Interwencyjnej. 2015;11:1-4.
  63. Kimura M, Kohno T, Kawakami T, Kataoka M, Inohara T, Takei M, et al. Balloon pulmonary angioplasty attenuates ongoing myocardial damage in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2016;207:387-389.
  64. Kawakami T, Ogawa A, Miyaji K, Mizoguchi H, Shimokawahara H, Naito T, et al. Novel angiographic classi cation of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty. Circ Cardiovasc Interv. 2016; 9:e003318.
  65. Ogawa A, Satoh T, Fukuda T, Sugimura K, Fukumoto Y, Emoto N, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Results of a multicenter registry. Circ Cardiovasc Qual Outcomes. 2017;10:e004029.
  66. Danilov NM, Matchin YG et al. Antecubital venous access for balloon pulmonary angioplasry in patients with chronic thromboembolic pulmonary hypertension. Eur Respir J. 2016;48:3596.
  67. Takumi I, Kataoka M, Shimura N, Ishiguro H, Yanagisawa R, Taguchi H, Fukuda K, Yoshino H. Pulmonary Edema Predictive Scoring Index (PEPSI), a New Index to Predict Risk of Reperfusion Pulmonary Edema and Improvement of Hemodynamics in Percutaneous Transluminal Pulmonary Angioplasty. JACC: Cardiovaskular Interventions. 2013.6(7),725-736. https://doi.org/10.1016/j.jcin.2013.03.09
  68. Nagayoshi S, Ogawa A, Matsubara H. Spontaneous enlargement of pulmonary artery after successful balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2016; 12:e1435.
  69. Kitani M, Ogawa A, Sarashina T, Yamadori I, Matsubara H. Histological changes of pulmonary arteries treated by balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2014;7:857-859.
  70. Inami T, Kataoka M, Ando M, et al. A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS One. 2014;9:e94587.
  71. Fukui S, Ogo T, Morita Y, Tsuji A, Tateishi E, Ozaki K, Sanda Y, Fukuda T, Yasuda S, Ogawa H, Nakanishi N. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J. 2014;43:1394-1402.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.